» Articles » PMID: 38471546

Building Pyramids Against the Evolutionary Emergence of Pathogens

Overview
Journal Proc Biol Sci
Specialty Biology
Date 2024 Mar 12
PMID 38471546
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations allowing pathogens to escape host immunity promote the spread of infectious diseases in heterogeneous host populations and can lead to major epidemics. Understanding the conditions that slow down this evolution is key for the development of durable control strategies against pathogens. Here, we use theory and experiments to compare the efficacy of three strategies for the deployment of resistance: (i) a strategy where the host population contains two single-resistant genotypes, (ii) a strategy where the host carries a double-resistant genotype, (iii) a strategy where the host population is a mix of a single-resistant genotype and a double-resistant genotype. First, we use evolutionary epidemiology theory to clarify the interplay between demographic stochasticity and evolutionary dynamics to show that the strategy always yields lower probability of evolutionary emergence. Second, we test experimentally these predictions with the introduction of bacteriophages into bacterial populations where we manipulated the diversity and the depth of immunity using a Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR associated (CRISPR-Cas) system. These biological assays confirm that pyramiding multiple defences into the same host genotype and avoiding combination with single-defence genotypes is a robust way to reduce pathogen evolutionary emergence. The experimental validation of these theoretical recommendations has practical implications in various areas, including for the optimal deployment of resistance varieties in agriculture and for the design of durable vaccination strategies.

Citing Articles

Building pyramids against the evolutionary emergence of pathogens.

Gandon S, Guillemet M, Gatchitch F, Nicot A, Renaud A, Tremblay D Proc Biol Sci. 2024; 291(2018):20231529.

PMID: 38471546 PMC: 10932699. DOI: 10.1098/rspb.2023.1529.


My host's enemy is my enemy: plasmids carrying CRISPR-Cas as a defence against phages.

Siedentop B, Ruegg D, Bonhoeffer S, Chabas H Proc Biol Sci. 2024; 291(2015):20232449.

PMID: 38262608 PMC: 10805597. DOI: 10.1098/rspb.2023.2449.

References
1.
Deveau H, Barrangou R, Garneau J, Labonte J, Fremaux C, Boyaval P . Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J Bacteriol. 2007; 190(4):1390-400. PMC: 2238228. DOI: 10.1128/JB.01412-07. View

2.
Common J, Morley D, Westra E, van Houte S . CRISPR-Cas immunity leads to a coevolutionary arms race between Streptococcus thermophilus and lytic phage. Philos Trans R Soc Lond B Biol Sci. 2019; 374(1772):20180098. PMC: 6452269. DOI: 10.1098/rstb.2018.0098. View

3.
Hastings I . How artemisinin-containing combination therapies slow the spread of antimalarial drug resistance. Trends Parasitol. 2010; 27(2):67-72. DOI: 10.1016/j.pt.2010.09.005. View

4.
Angst D, Tepekule B, Sun L, Bogos B, Bonhoeffer S . Comparing treatment strategies to reduce antibiotic resistance in an in vitro epidemiological setting. Proc Natl Acad Sci U S A. 2021; 118(13). PMC: 8020770. DOI: 10.1073/pnas.2023467118. View

5.
Brown J . Durable resistance of crops to disease: a Darwinian perspective. Annu Rev Phytopathol. 2015; 53:513-39. DOI: 10.1146/annurev-phyto-102313-045914. View